Nestin and CD34 expression in colorectal cancer predicts improved overall survival.

Tampakis, Athanasios; Weixler, Benjamin; Rast, Silvan; Tampaki, Ekaterini-Christina; Cremonesi, Eleonora; Kancherla, Venkatesh; Tosti, Nadia; Kettelhack, Christoph; Ng, Charlotte K Y; Delko, Tarik; Soysal, Savas D; von Holzen, Urs; Felekouras, Evangelos; Nikiteas, Nikolaos; Bolli, Martin; Tornillo, Luigi; Terracciano, Luigi; Eppenberger-Castori, Serenella; Spagnoli, Giulio C; Piscuoglio, Salvatore; ... (2021). Nestin and CD34 expression in colorectal cancer predicts improved overall survival. Acta oncologica, 60(6), pp. 727-734. Taylor & Francis 10.1080/0284186X.2021.1891280

[img] Text
0284186X.2021.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB)

BACKGROUND

Nestin, a class VI intermediate filament protein of the cytoskeleton, and CD34, a transmembrane phosphoglycoprotein, are markers of progenitor cells. This study aimed to evaluate their expression and clinical significance in colorectal cancer.

METHODS

A clinically annotated tissue microarray, including 599 patients with colorectal cancer, was analyzed by immunohistochemistry. Furthermore, nestin and CD34 correlations with HIF-1a and a panel of cytokines and chemokines were assessed using quantitative reverse transcription PCR and The Cancer Genome Atlas dataset.

RESULTS

Expression of nestin and CD34 was observed only in the tumor stroma. Patients displaying high expression of nestin and CD34 demonstrated higher rates of T1 and T2 tumors (p = .020), lower vascular invasion (p < .001) and improved 5-year overall survival (65%; 95% CI = 55-73 vs 45%; 95% CI = 37-53) after adjusting for clinicopathological characteristics (HR: 0.67; 95% CI = 0.46-0.96). A moderate to strong correlation (r = 0.37-0.78, p < .03) of nestin and CD34 was demonstrated for the following markers; HIF-1α, CD4, CD8, FOXP3, IRF1, GATA3, CCL2, CCL3, CXCL12 and CCL21.

CONCLUSIONS

Combined expression of nestin and CD34 expression is associated with better overall survival possibly by modulating a favorable immune response.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Ng, Kiu Yan Charlotte

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1651-226X

Publisher:

Taylor & Francis

Language:

English

Submitter:

Marla Rittiner

Date Deposited:

21 Jan 2022 15:10

Last Modified:

05 Dec 2022 16:00

Publisher DOI:

10.1080/0284186X.2021.1891280

PubMed ID:

33734917

Uncontrolled Keywords:

CD34 Nestin colorectal cancer hypoxia associated immune response tumor microenvironment

BORIS DOI:

10.48350/163422

URI:

https://boris.unibe.ch/id/eprint/163422

Actions (login required)

Edit item Edit item
Provide Feedback